Skip to main content
Log in

Cyclophosphamide + azathioprine best option for LN in Thailand

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Mohara A, et al. A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Rheumatology : 4 Oct 2013. Available from: URL: http://dx.doi.org/10.1093/rheumatology/ket304

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyclophosphamide + azathioprine best option for LN in Thailand. PharmacoEcon Outcomes News 690, 5 (2013). https://doi.org/10.1007/s40274-013-0821-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0821-8

Navigation